Q2 FY2026 · ended Jun 30, 2026 · Revenue $47.28M, -3.5% YoY · Filed Aug 5, 2026
LifeMD, Inc. (LFMD) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $47.3 million and a net loss of $7.1 million. Free cash flow was -$7.0 million. As of Jun 30, 2026 it held $25.1 million in cash and investments and $6.0 million in total debt.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- LFMD (Nasdaq), LFMDP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 948320
- Former names
- CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $47.3M | $50.2M | $7.1M | $60.2M | $49.0M |
| Operating income | -$7.1M | -$8.9M | -$6.2M | -$2.0M | -$2.3M |
| Net income | -$7.1M | -$8.9M | $20.0M | -$3.8M | -$1.6M |
| Diluted EPS | -$0.16 | -$0.20 | $0.41 | — | -$0.05 |
| Operating cash flow | -$6.9M | $444,624 | -$3.3M | -$147,136 | $8.6M |
| Free cash flow | -$7.0M | $339,446 | -$3.4M | -$968,135 | $7.9M |
| Total assets | $59.9M | $70.1M | $70.4M | $66.0M | $73.6M |
| Total liabilities | $51.9M | $55.1M | $47.3M | $62.6M | $73.2M |
| Stockholders' equity | $8.0M | $15.0M | $23.2M | $1.3M | -$1.8M |
| Cash and investments | $25.1M | $34.5M | $36.8M | $23.8M | — |
| Total debt | $6.0M | $6.2M | $6.3M | $6.5M | $22.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
All 578 LifeMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.